Assessing and mitigating privacy risks of sparse, noisy genotypes by local alignment to haplotype databases
Genome Research · 2023
DOI: 10.1101/gr.278322.123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome Research, 2023. Verfasst von Prashant S Emani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut 06520, USA. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Haplotypes, Genotype. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Single nucleotide polymorphisms (SNPs) from omics data create a reidentification risk for individuals and their relatives. Although the ability of thousands of SNPs (especially rare ones) to identify individuals has been repeatedly shown, the availability of small sets of noisy genotypes, from environmental DNA samples or functional genomics data, motivated us to quantify their informativeness. We present a computational tool suite, termed Privacy Leakage by Inference across Genotypic HMM Trajectories (PLIGHT), using population-genetics-based hidden Markov models (HMMs) of recombination and mutation to find piecewise alignment of small, noisy SNP sets to reference haplotype databases. We explore cases in which query individuals are either known to be in the database, or not, and consider several genotype queries, including those from environmental sample swabs from known individuals and from simulated “mosaics” (two-individual composites). Using PLIGHT on a database with ∼5000 haplotypes, we find for common, noise-free SNPs that only ten are sufficient to identify individuals, ∼20 can identify both components in two-individual mosaics, and 20–30 can identify first-order relatives. Using noisy environmental-sample-derived SNPs, PLIGHT identifies individuals in a database using ∼30 SNPs. Even when the individuals are not in the database, local genotype matches allow for some phenotypic information leakage based on coarse-grained SNP imputation. Finally, by quantifying privacy leakage from sparse SNP sets, PLIGHT helps determine the value of selectively sanitizing released SNPs without explicit assumptions about population membership or allele frequency. To make this practical, we provide a sanitization tool to remove the most identifying SNPs from genomic data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut 06520, USA.
- Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06520, USA.
- Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut 06520, USA; mark@gersteinlab.org.
- Department of Computer Science, Yale University, New Haven, Connecticut 06520, USA.
- Department of Statistics and Data Science, Yale University, New Haven, Connecticut 06520, USA.
ORCID-Profile: Prashant S Emani, Gamze Gürsoy, Andrew Miranker, Mark B Gerstein
Förderung
- NHGRI NIH HHS
- National Institutes of Health
Zitieren
APA
Emani, P. S., Geradi, M. N., Gürsoy, G., Grasty, M. R., Miranker, A., & Gerstein, M. B. (2023). Assessing and mitigating privacy risks of sparse, noisy genotypes by local alignment to haplotype databases. Genome Research. https://doi.org/10.1101/gr.278322.123
Vancouver
Emani PS, Geradi MN, Gürsoy G, Grasty MR, Miranker A, Gerstein MB. Assessing and mitigating privacy risks of sparse, noisy genotypes by local alignment to haplotype databases. Genome Research. 2023. doi:10.1101/gr.278322.123
BibTeX
@article{Emani2023,
author = {Emani, Prashant S and Geradi, Maya N and Gürsoy, Gamze and Grasty, Monica R and Miranker, Andrew and Gerstein, Mark B},
title = {Assessing and mitigating privacy risks of sparse, noisy genotypes by local alignment to haplotype databases},
journal = {Genome Research},
year = {2023},
doi = {10.1101/gr.278322.123}
}
EUVIMED